2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid
C19H26N2O5 — CID 122100810
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid
2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid (PubChem CID 122100810) has the molecular formula C19H26N2O5 and a molecular weight of 362.43 g/mol. Its IUPAC name is 2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid.
Molecular Properties
| Compound Name | 2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid |
|---|---|
| PubChem CID | 122100810 |
| Molecular Formula | C19H26N2O5 |
| Molecular Weight | 362.43 g/mol |
| Exact Mass | 362.18 |
| IUPAC Name | 2-[cyclopropyl-[2-[2,3-dihydro-1,4-benzodioxin-3-ylmethyl(ethyl)amino]-2-oxoethyl]amino]propanoic acid |
| SMILES | CCN(CC1COc2ccccc2O1)C(=O)CN(C1CC1)C(C)C(=O)O |
| InChI | InChI=1S/C19H26N2O5/c1-3-20(10-15-12-25-16-6-4-5-7-17(16)26-15)18(22)11-21(14-8-9-14)13(2)19(23)24/h4-7,13-15H,3,8-12H2,1-2H3,(H,23,24) |
| InChIKey | MKJMAZAIEVXRDR-UHFFFAOYSA-N |
| XLogP | 1.61 |
| TPSA | 79.31 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.43 |
| LogP ≤ 5 | 1.61 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122100810 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.